Pregnancy outcomes from the pregnancy registry of a human papillomavirus type6/11/16/18 vaccine

Obstetrics and Gynecology

Volumn 114, Issue 6, 2009, Pages 1170-1178

  Dana, Adrian ^a   Buchanan, Karyn M ^b   Goss, Mary Ann ^b   Seminack, Margaret M ^b   Shields, Kristine E ^b   Korn, Scott ^b   Cunningham, Michael L ^b   Haupt, Richard M ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; CHICKENPOX VACCINE; FERROUS SULFATE; FOLIC ACID; HEPATITIS A VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; METHYLPHENIDATE; ORAL CONTRACEPTIVE AGENT; PREDNISONE; VITAMIN; WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;

ADOLESCENT; ADULT; ANENCEPHALUS; ARTHROGRYPOSIS; ARTICLE; BIRTH DEFECT; CHILD; CLEFT LIP; CLEFT PALATE; CONDYLOMA ACUMINATUM; CONGENITAL NEVUS; DEATH; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; FETUS DEATH; GASTROSCHISIS; HEART ATRIUM SEPTUM DEFECT; HIP DYSPLASIA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HYDROCELE; HYPOPLASTIC LEFT HEART SYNDROME; HYPOSPADIAS; INTRAUTERINE GROWTH RETARDATION; KIDNEY AGENESIS; KIDNEY MALFORMATION; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MICROGYRIA; NEWBORN; PATENT DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PLACENTA DISORDER; POLYDACTYLY; POSTMARKETING SURVEILLANCE; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRIORITY JOURNAL; PRUNE BELLY SYNDROME; PULMONARY VALVE STENOSIS; SCHIZENCEPHALY; SCHOOL CHILD; SIDE EFFECT; SPONTANEOUS ABORTION; TRISOMY 21; UTERINE CERVIX CANCER; VACCINATION; VAGINA CANCER; VULVA CANCER; CANADA; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; FRANCE; PREGNANCY; REGISTER; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; CANADA; CHILD; FEMALE; FETAL DEATH; FRANCE; HUMANS; PAPILLOMAVIRUS VACCINES; PREGNANCY; PREGNANCY OUTCOME; PRODUCT SURVEILLANCE, POSTMARKETING; REGISTRIES; UNITED STATES; YOUNG ADULT;

EID: 73349127849     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181c2a122     Document Type: Article

References (21)

1. Barr E, Sings HL. Prophylactic HPV vaccines: new interventions for cancer control. Vaccine 2008;26:6244-6257
2. Lehman HP, Benson JO, Beninger PR, Anderson CA, Blu-menthal SJ, Sharrar RG. A five-year evaluation of reports of overdose with indinavir sulfate. Pharmacoepidemiol Drug Saf 2003;12:449-457
3. Centers for Disease Control and Prevention, Metropolitan Atlanta Congenital Defects Program. Surveillance procedure manual and guide to computerized anomaly record. Atlanta (GA): Centers for Disease Control and Prevention; 1998.
4. Centers for Disease Control and Prevention. Birth defects and genetic diseases branch 6-digit code for reportable congenital anomalies. Version 08/07. Available at: http://www.cdc.gov/ ncbddd/bd/documents/MACDPcode%200807.pdf. Retrieved February 2, 2009.
5. March of Dimes. Available at: http://www.marchofdimes. com. Retrieved January 28, 2009.
6. Correa A, Cragan JD, Kucik JE, Alverson CJ, Gilboa SM, Balakrishnan R, et al. Reporting birth defects surveillance data 1968-2003 [published erratum appears in Birth Defects Res A Clin Mol Teratol 2008;82:41-62]. Birth Defects Res A Clin Mol Teratol 2007;79:65-186.
7. MacDorman MF, Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 2009;57(8):1-19.
8. Ventura SJ, Abma JC, Mosher WD, Henshaw S. Estimated pregnancy rates for the United States, 1990-2000: an update. Natl Vital Stat Rep 2004;52(23):1-9.
9. Lilienfeld DE, Stolley PD. Foundations of epidemiology. 3rd ed. New York (NY): Oxford Press; 1994.
10. Merck & Co., Inc. Pregnancy Registry for GARDASIL. Available at: http://www.merckpregnancyregistries.com/gardasil. html. Retrieved January 28, 2009.
11. Koren G, Bologa M, Long D, Feldman Y, Shear NH. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol 1989;160:1190-1194
12. Pole M, Einarson A, Pairaudeau N, Einarson T, Koren G. Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. J Clin Pharmacol 2000;40:573-577
13. U.S. Food and Drug Administration. Guidance for industry: establishing pregnancy exposure registries. August 2002. Available at: http://www.fda.gov/ downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/UCM071639. pdf. Retrieved June 8, 2009.
14. Scott JR. Early pregnancy loss. In: Scott JR, DiSaia PJ, Hammond CB, Spellacy WN, editors. Danforth's obstetrics and gynecology. Philadelphia (PA): Lippincott Williams & Wilkins; 1999. p. 143-153
15. Fox R, Pillai M, Porter H, Gill G. The management of late fetal death: a guide to comprehensive care. Br J Obstet Gynaecol 1997;104:4-10.
16. Curry CJ, Lammer EJ, Nelson V, Shaw GM. Schizencephaly: heterogeneous etiologies in a population of 4 million California births. Am J Med Genet A 2005;137:181-189
17. Mathews TJ, Honein MA, Erickson JD. Spina bifida and anencephaly prevalence: United States, 1991-2001. MMWR Recomm Rep 2002;51(RR-13):9-11.
18. Wynbrandt J, Ludman MD. The encyclopedia of genetic disorders and birth defects. 3rd ed. New York (NY): Fact on File, Inc.; 2008.
19. Krapels IP, Vermeij-Keers C, Muller M, de Klein A, Steegers-Theunissen RP. Nutrition and genes in the development of orofacial clefting. Nutr Rev 2006;64:280-288
20. Wilson E, Goss MA, Marin M, Shields KE, Seward JF, Rasmussen SA, et al. Varicella vaccine exposure during pregnancy: data from 10 years of the pregnancy registry. J Infect Dis 2008;197(suppl 2):S178-84.
21. Ryan MA, Seward JF; Smallpox Vaccine in Pregnancy Registry Team. Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006. Clin Infect Dis 2008;46(suppl 3):S221-6